Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W E Klunk

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Neurobiology of Aging|April 29, 1998
Biological markers of Alzheimer's diseaseW E Klunk
Journal of Neurochemistry|June 1, 1990
Alzheimer's beta-amyloid protein is covalently modified when dissolved in formic acidW E Klunk, J W Pettegrew
Psychiatric Developments|January 1, 1988
Filamentous proteins in Alzheimer's disease: new insights through molecular biologyW E Klunk, D J Abraham
Current Pharmaceutical Design|May 12, 2004
Imaging beta-amyloid plaques and neurofibrillary tangles in the aging human brainC A Mathis, Y Wang, W E Klunk
Biochemical Pharmacology|October 15, 1983
Alkyl-substituted gamma-butyrolactones as potential tools in the study and treatment of epilepsyW E Klunk, D F Covey, J A Ferrendelli
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|August 1, 1989
Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformationW E Klunk, J W Pettegrew, D J Abraham
Molecular and Chemical Neuropathology|August 1, 1991
Possible roles of L-phosphoserine in the pathogenesis of Alzheimer's diseaseW E Klunk, R J McClure, J W Pettegrew
Journal of Neurochemistry|January 1, 1994
NMR identification of the formic acid-modified residue in Alzheimer's amyloid proteinW E Klunk, C J Xu, J W Pettegrew
Neurobiology of Aging|November 1, 1994
Development of small molecule probes for the beta-amyloid protein of Alzheimer's diseaseW E Klunk, M L Debnath, J W Pettegrew
Neurobiology of Aging|July 1, 1995
Chrysamine-G binding to Alzheimer and control brain: autopsy study of a new amyloid probeW E Klunk, M L Debnath, J W Pettegrew
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Neurobiology of Aging|April 29, 1998
Biological markers of Alzheimer's diseaseW E Klunk
Journal of Neurochemistry|June 1, 1990
Alzheimer's beta-amyloid protein is covalently modified when dissolved in formic acidW E Klunk, J W Pettegrew
Psychiatric Developments|January 1, 1988
Filamentous proteins in Alzheimer's disease: new insights through molecular biologyW E Klunk, D J Abraham
Current Pharmaceutical Design|May 12, 2004
Imaging beta-amyloid plaques and neurofibrillary tangles in the aging human brainC A Mathis, Y Wang, W E Klunk
Biochemical Pharmacology|October 15, 1983
Alkyl-substituted gamma-butyrolactones as potential tools in the study and treatment of epilepsyW E Klunk, D F Covey, J A Ferrendelli
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|August 1, 1989
Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformationW E Klunk, J W Pettegrew, D J Abraham
Molecular and Chemical Neuropathology|August 1, 1991
Possible roles of L-phosphoserine in the pathogenesis of Alzheimer's diseaseW E Klunk, R J McClure, J W Pettegrew
Journal of Neurochemistry|January 1, 1994
NMR identification of the formic acid-modified residue in Alzheimer's amyloid proteinW E Klunk, C J Xu, J W Pettegrew
Neurobiology of Aging|November 1, 1994
Development of small molecule probes for the beta-amyloid protein of Alzheimer's diseaseW E Klunk, M L Debnath, J W Pettegrew
Neurobiology of Aging|July 1, 1995
Chrysamine-G binding to Alzheimer and control brain: autopsy study of a new amyloid probeW E Klunk, M L Debnath, J W Pettegrew
Pageof 6